DiaMedica Therapeutics Inc.
DMAC
$5.42
-$0.19-3.39%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.90% | -1.39% | -11.96% | 0.10% | 2.44% |
| Total Depreciation and Amortization | 0.00% | -38.89% | 500.00% | -72.73% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.95% | 21.95% | 28.97% | -2.40% | 125.18% |
| Change in Net Operating Assets | 9,733.33% | -99.76% | 346.39% | -549.37% | -106.71% |
| Cash from Operations | -16.96% | -18.55% | 13.79% | -6.28% | -11.11% |
| Capital Expenditure | -33.33% | 62.50% | -166.67% | 50.00% | -71.43% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -126.32% | 131.07% | -387.29% | 35.11% | 27.28% |
| Cash from Investing | -126.44% | 131.03% | -387.66% | 35.26% | 27.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -50.00% | 33.33% | -50.00% | 33.33% | 0.00% |
| Issuance of Common Stock | -96.51% | -62.37% | 19,526.99% | 73.40% | -23.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 112.28% | -- | -- | -- |
| Cash from Financing | -96.55% | -61.66% | 19,485.71% | 76.92% | -24.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -187.48% | 1,673.56% | -151.51% | 448.62% | 60.69% |